nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—psoriasis—systemic scleroderma	0.842	1	CtDrD
Hydroxyurea—RRM2—skin of body—systemic scleroderma	0.000582	0.144	CbGeAlD
Hydroxyurea—RRM1—smooth muscle tissue—systemic scleroderma	0.00049	0.121	CbGeAlD
Hydroxyurea—RRM1—skin of body—systemic scleroderma	0.000484	0.12	CbGeAlD
Hydroxyurea—RRM2—digestive system—systemic scleroderma	0.000466	0.115	CbGeAlD
Hydroxyurea—RRM2—tendon—systemic scleroderma	0.000443	0.11	CbGeAlD
Hydroxyurea—RRM2—lung—systemic scleroderma	0.000389	0.0961	CbGeAlD
Hydroxyurea—RRM1—digestive system—systemic scleroderma	0.000387	0.0956	CbGeAlD
Hydroxyurea—RRM1—tendon—systemic scleroderma	0.000368	0.091	CbGeAlD
Hydroxyurea—RRM1—lung—systemic scleroderma	0.000323	0.0798	CbGeAlD
Hydroxyurea—Alopecia—Lisinopril—systemic scleroderma	0.000194	0.00126	CcSEcCtD
Hydroxyurea—Dyspepsia—Captopril—systemic scleroderma	0.000194	0.00125	CcSEcCtD
Hydroxyurea—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00125	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Methotrexate—systemic scleroderma	0.000193	0.00125	CcSEcCtD
Hydroxyurea—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00125	CcSEcCtD
Hydroxyurea—Dizziness—Pentoxifylline—systemic scleroderma	0.000192	0.00124	CcSEcCtD
Hydroxyurea—Decreased appetite—Captopril—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Hydroxyurea—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Hydroxyurea—Malaise—Mycophenolic acid—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Hydroxyurea—Erythema—Lisinopril—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Hydroxyurea—Infection—Azathioprine—systemic scleroderma	0.000191	0.00124	CcSEcCtD
Hydroxyurea—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00019	0.00123	CcSEcCtD
Hydroxyurea—Fatigue—Captopril—systemic scleroderma	0.00019	0.00123	CcSEcCtD
Hydroxyurea—Constipation—Captopril—systemic scleroderma	0.000188	0.00122	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000188	0.00122	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000188	0.00122	CcSEcCtD
Hydroxyurea—Discomfort—Leflunomide—systemic scleroderma	0.000187	0.00121	CcSEcCtD
Hydroxyurea—Skin disorder—Azathioprine—systemic scleroderma	0.000187	0.00121	CcSEcCtD
Hydroxyurea—Vomiting—Pentoxifylline—systemic scleroderma	0.000185	0.0012	CcSEcCtD
Hydroxyurea—Convulsion—Mycophenolic acid—systemic scleroderma	0.000184	0.00119	CcSEcCtD
Hydroxyurea—Rash—Pentoxifylline—systemic scleroderma	0.000183	0.00119	CcSEcCtD
Hydroxyurea—Dermatitis—Pentoxifylline—systemic scleroderma	0.000183	0.00118	CcSEcCtD
Hydroxyurea—Headache—Pentoxifylline—systemic scleroderma	0.000182	0.00118	CcSEcCtD
Hydroxyurea—Face oedema—Prednisone—systemic scleroderma	0.000182	0.00118	CcSEcCtD
Hydroxyurea—Feeling abnormal—Captopril—systemic scleroderma	0.000182	0.00117	CcSEcCtD
Hydroxyurea—Infection—Leflunomide—systemic scleroderma	0.00018	0.00117	CcSEcCtD
Hydroxyurea—Asthenia—Mometasone—systemic scleroderma	0.00018	0.00116	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000179	0.00116	CcSEcCtD
Hydroxyurea—Discomfort—Mycophenolic acid—systemic scleroderma	0.000179	0.00116	CcSEcCtD
Hydroxyurea—Nervous system disorder—Leflunomide—systemic scleroderma	0.000178	0.00115	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000178	0.00115	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000177	0.00115	CcSEcCtD
Hydroxyurea—Anaemia—Lisinopril—systemic scleroderma	0.000177	0.00114	CcSEcCtD
Hydroxyurea—Skin disorder—Leflunomide—systemic scleroderma	0.000176	0.00114	CcSEcCtD
Hydroxyurea—Hepatic failure—Methotrexate—systemic scleroderma	0.000175	0.00113	CcSEcCtD
Hydroxyurea—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000175	0.00113	CcSEcCtD
Hydroxyurea—Body temperature increased—Captopril—systemic scleroderma	0.000174	0.00113	CcSEcCtD
Hydroxyurea—Oedema—Mycophenolic acid—systemic scleroderma	0.000173	0.00112	CcSEcCtD
Hydroxyurea—Anorexia—Leflunomide—systemic scleroderma	0.000173	0.00112	CcSEcCtD
Hydroxyurea—Nausea—Pentoxifylline—systemic scleroderma	0.000173	0.00112	CcSEcCtD
Hydroxyurea—Chills—Mycophenolate mofetil—systemic scleroderma	0.000173	0.00112	CcSEcCtD
Hydroxyurea—Malaise—Lisinopril—systemic scleroderma	0.000172	0.00112	CcSEcCtD
Hydroxyurea—Infection—Mycophenolic acid—systemic scleroderma	0.000172	0.00111	CcSEcCtD
Hydroxyurea—Diarrhoea—Mometasone—systemic scleroderma	0.000172	0.00111	CcSEcCtD
Hydroxyurea—Leukopenia—Lisinopril—systemic scleroderma	0.000171	0.00111	CcSEcCtD
Hydroxyurea—Renal failure acute—Methotrexate—systemic scleroderma	0.000171	0.0011	CcSEcCtD
Hydroxyurea—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00017	0.0011	CcSEcCtD
Hydroxyurea—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00017	0.0011	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00017	0.0011	CcSEcCtD
Hydroxyurea—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000168	0.00109	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000166	0.00107	CcSEcCtD
Hydroxyurea—Anorexia—Mycophenolic acid—systemic scleroderma	0.000165	0.00107	CcSEcCtD
Hydroxyurea—Dyspnoea—Leflunomide—systemic scleroderma	0.000162	0.00105	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000162	0.00105	CcSEcCtD
Hydroxyurea—Discomfort—Lisinopril—systemic scleroderma	0.000161	0.00104	CcSEcCtD
Hydroxyurea—Dyspepsia—Leflunomide—systemic scleroderma	0.00016	0.00103	CcSEcCtD
Hydroxyurea—Pancreatitis—Prednisone—systemic scleroderma	0.00016	0.00103	CcSEcCtD
Hydroxyurea—Vomiting—Mometasone—systemic scleroderma	0.000159	0.00103	CcSEcCtD
Hydroxyurea—Feeling abnormal—Azathioprine—systemic scleroderma	0.000158	0.00103	CcSEcCtD
Hydroxyurea—Rash—Mometasone—systemic scleroderma	0.000158	0.00102	CcSEcCtD
Hydroxyurea—Asthenia—Captopril—systemic scleroderma	0.000158	0.00102	CcSEcCtD
Hydroxyurea—Dermatitis—Mometasone—systemic scleroderma	0.000158	0.00102	CcSEcCtD
Hydroxyurea—Decreased appetite—Leflunomide—systemic scleroderma	0.000158	0.00102	CcSEcCtD
Hydroxyurea—Headache—Mometasone—systemic scleroderma	0.000157	0.00102	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000157	0.00101	CcSEcCtD
Hydroxyurea—Fatigue—Leflunomide—systemic scleroderma	0.000157	0.00101	CcSEcCtD
Hydroxyurea—Oedema—Lisinopril—systemic scleroderma	0.000156	0.00101	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00101	CcSEcCtD
Hydroxyurea—Pain—Leflunomide—systemic scleroderma	0.000155	0.001	CcSEcCtD
Hydroxyurea—Constipation—Leflunomide—systemic scleroderma	0.000155	0.001	CcSEcCtD
Hydroxyurea—Infection—Lisinopril—systemic scleroderma	0.000155	0.001	CcSEcCtD
Hydroxyurea—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.001	CcSEcCtD
Hydroxyurea—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000154	0.000999	CcSEcCtD
Hydroxyurea—Somnolence—Mycophenolic acid—systemic scleroderma	0.000154	0.000996	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000153	0.000988	CcSEcCtD
Hydroxyurea—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000152	0.000987	CcSEcCtD
Hydroxyurea—Neutropenia—Prednisone—systemic scleroderma	0.000152	0.000986	CcSEcCtD
Hydroxyurea—Body temperature increased—Azathioprine—systemic scleroderma	0.000152	0.000984	CcSEcCtD
Hydroxyurea—Skin disorder—Lisinopril—systemic scleroderma	0.000152	0.000981	CcSEcCtD
Hydroxyurea—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000977	CcSEcCtD
Hydroxyurea—Diarrhoea—Captopril—systemic scleroderma	0.000151	0.000975	CcSEcCtD
Hydroxyurea—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000151	0.000974	CcSEcCtD
Hydroxyurea—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00097	CcSEcCtD
Hydroxyurea—Feeling abnormal—Leflunomide—systemic scleroderma	0.00015	0.000968	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00015	0.000968	CcSEcCtD
Hydroxyurea—Fatigue—Mycophenolic acid—systemic scleroderma	0.000149	0.000966	CcSEcCtD
Hydroxyurea—Nausea—Mometasone—systemic scleroderma	0.000149	0.000964	CcSEcCtD
Hydroxyurea—Anorexia—Lisinopril—systemic scleroderma	0.000149	0.000962	CcSEcCtD
Hydroxyurea—Weight increased—Prednisone—systemic scleroderma	0.000148	0.00096	CcSEcCtD
Hydroxyurea—Pain—Mycophenolic acid—systemic scleroderma	0.000148	0.000958	CcSEcCtD
Hydroxyurea—Constipation—Mycophenolic acid—systemic scleroderma	0.000148	0.000958	CcSEcCtD
Hydroxyurea—Dizziness—Captopril—systemic scleroderma	0.000146	0.000943	CcSEcCtD
Hydroxyurea—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000939	CcSEcCtD
Hydroxyurea—Body temperature increased—Leflunomide—systemic scleroderma	0.000144	0.000929	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000143	0.000924	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000142	0.000922	CcSEcCtD
Hydroxyurea—Breast disorder—Methotrexate—systemic scleroderma	0.000142	0.000921	CcSEcCtD
Hydroxyurea—Hypersensitivity—Azathioprine—systemic scleroderma	0.000142	0.000917	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000916	CcSEcCtD
Hydroxyurea—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000912	CcSEcCtD
Hydroxyurea—Vomiting—Captopril—systemic scleroderma	0.00014	0.000906	CcSEcCtD
Hydroxyurea—Dyspnoea—Lisinopril—systemic scleroderma	0.000139	0.0009	CcSEcCtD
Hydroxyurea—Rash—Captopril—systemic scleroderma	0.000139	0.000899	CcSEcCtD
Hydroxyurea—Dermatitis—Captopril—systemic scleroderma	0.000139	0.000898	CcSEcCtD
Hydroxyurea—Somnolence—Lisinopril—systemic scleroderma	0.000139	0.000898	CcSEcCtD
Hydroxyurea—Headache—Captopril—systemic scleroderma	0.000138	0.000893	CcSEcCtD
Hydroxyurea—Dyspepsia—Lisinopril—systemic scleroderma	0.000137	0.000889	CcSEcCtD
Hydroxyurea—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000137	0.000886	CcSEcCtD
Hydroxyurea—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000885	CcSEcCtD
Hydroxyurea—Infection—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000879	CcSEcCtD
Hydroxyurea—Decreased appetite—Lisinopril—systemic scleroderma	0.000136	0.000878	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000135	0.000872	CcSEcCtD
Hydroxyurea—Fatigue—Lisinopril—systemic scleroderma	0.000134	0.00087	CcSEcCtD
Hydroxyurea—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000867	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000866	CcSEcCtD
Hydroxyurea—Hypersensitivity—Leflunomide—systemic scleroderma	0.000134	0.000866	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—systemic scleroderma	0.000134	0.000864	CcSEcCtD
Hydroxyurea—Pain—Lisinopril—systemic scleroderma	0.000133	0.000863	CcSEcCtD
Hydroxyurea—Constipation—Lisinopril—systemic scleroderma	0.000133	0.000863	CcSEcCtD
Hydroxyurea—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000859	CcSEcCtD
Hydroxyurea—Diarrhoea—Azathioprine—systemic scleroderma	0.000132	0.000851	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisone—systemic scleroderma	0.000131	0.000848	CcSEcCtD
Hydroxyurea—Nausea—Captopril—systemic scleroderma	0.000131	0.000847	CcSEcCtD
Hydroxyurea—Haemorrhage—Prednisone—systemic scleroderma	0.00013	0.000844	CcSEcCtD
Hydroxyurea—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000843	CcSEcCtD
Hydroxyurea—Asthenia—Leflunomide—systemic scleroderma	0.00013	0.000843	CcSEcCtD
Hydroxyurea—Hallucination—Prednisone—systemic scleroderma	0.00013	0.00084	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—systemic scleroderma	0.000129	0.000837	CcSEcCtD
Hydroxyurea—Feeling abnormal—Lisinopril—systemic scleroderma	0.000129	0.000832	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—systemic scleroderma	0.000127	0.000824	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—systemic scleroderma	0.000127	0.000824	CcSEcCtD
Hydroxyurea—Dizziness—Azathioprine—systemic scleroderma	0.000127	0.000823	CcSEcCtD
Hydroxyurea—Asthenia—Mycophenolic acid—systemic scleroderma	0.000124	0.000804	CcSEcCtD
Hydroxyurea—Diarrhoea—Leflunomide—systemic scleroderma	0.000124	0.000804	CcSEcCtD
Hydroxyurea—Body temperature increased—Lisinopril—systemic scleroderma	0.000123	0.000798	CcSEcCtD
Hydroxyurea—Vomiting—Azathioprine—systemic scleroderma	0.000122	0.000791	CcSEcCtD
Hydroxyurea—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000789	CcSEcCtD
Hydroxyurea—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000786	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—systemic scleroderma	0.000121	0.000786	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—systemic scleroderma	0.000121	0.000786	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—systemic scleroderma	0.000121	0.000786	CcSEcCtD
Hydroxyurea—Rash—Azathioprine—systemic scleroderma	0.000121	0.000784	CcSEcCtD
Hydroxyurea—Dermatitis—Azathioprine—systemic scleroderma	0.000121	0.000784	CcSEcCtD
Hydroxyurea—Headache—Azathioprine—systemic scleroderma	0.00012	0.000779	CcSEcCtD
Hydroxyurea—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.000779	CcSEcCtD
Hydroxyurea—Dizziness—Leflunomide—systemic scleroderma	0.00012	0.000777	CcSEcCtD
Hydroxyurea—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000769	CcSEcCtD
Hydroxyurea—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000119	0.000767	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—systemic scleroderma	0.000118	0.000766	CcSEcCtD
Hydroxyurea—Angiopathy—Prednisone—systemic scleroderma	0.000118	0.000766	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000764	CcSEcCtD
Hydroxyurea—Pain—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000756	CcSEcCtD
Hydroxyurea—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000756	CcSEcCtD
Hydroxyurea—Vomiting—Leflunomide—systemic scleroderma	0.000115	0.000747	CcSEcCtD
Hydroxyurea—Alopecia—Prednisone—systemic scleroderma	0.000115	0.000746	CcSEcCtD
Hydroxyurea—CYP2D6—digestive system—systemic scleroderma	0.000115	0.0284	CbGeAlD
Hydroxyurea—Hypersensitivity—Lisinopril—systemic scleroderma	0.000115	0.000744	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000115	0.000743	CcSEcCtD
Hydroxyurea—Dizziness—Mycophenolic acid—systemic scleroderma	0.000115	0.000741	CcSEcCtD
Hydroxyurea—Rash—Leflunomide—systemic scleroderma	0.000114	0.000741	CcSEcCtD
Hydroxyurea—Dermatitis—Leflunomide—systemic scleroderma	0.000114	0.00074	CcSEcCtD
Hydroxyurea—Nausea—Azathioprine—systemic scleroderma	0.000114	0.000739	CcSEcCtD
Hydroxyurea—Headache—Leflunomide—systemic scleroderma	0.000114	0.000736	CcSEcCtD
Hydroxyurea—Erythema—Prednisone—systemic scleroderma	0.000114	0.000735	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000729	CcSEcCtD
Hydroxyurea—Asthenia—Lisinopril—systemic scleroderma	0.000112	0.000724	CcSEcCtD
Hydroxyurea—Vomiting—Mycophenolic acid—systemic scleroderma	0.00011	0.000713	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—systemic scleroderma	0.00011	0.000709	CcSEcCtD
Hydroxyurea—Rash—Mycophenolic acid—systemic scleroderma	0.000109	0.000707	CcSEcCtD
Hydroxyurea—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000109	0.000706	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—systemic scleroderma	0.000109	0.000705	CcSEcCtD
Hydroxyurea—Headache—Mycophenolic acid—systemic scleroderma	0.000109	0.000702	CcSEcCtD
Hydroxyurea—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000699	CcSEcCtD
Hydroxyurea—Nausea—Leflunomide—systemic scleroderma	0.000108	0.000698	CcSEcCtD
Hydroxyurea—Diarrhoea—Lisinopril—systemic scleroderma	0.000107	0.000691	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisone—systemic scleroderma	0.000105	0.000682	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—systemic scleroderma	0.000105	0.000679	CcSEcCtD
Hydroxyurea—Dizziness—Lisinopril—systemic scleroderma	0.000103	0.000668	CcSEcCtD
Hydroxyurea—Nausea—Mycophenolic acid—systemic scleroderma	0.000103	0.000666	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—systemic scleroderma	0.000102	0.000663	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000652	CcSEcCtD
Hydroxyurea—Vomiting—Lisinopril—systemic scleroderma	9.92e-05	0.000642	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—systemic scleroderma	9.89e-05	0.00064	CcSEcCtD
Hydroxyurea—Rash—Lisinopril—systemic scleroderma	9.84e-05	0.000637	CcSEcCtD
Hydroxyurea—Convulsion—Prednisone—systemic scleroderma	9.84e-05	0.000637	CcSEcCtD
Hydroxyurea—Dermatitis—Lisinopril—systemic scleroderma	9.83e-05	0.000636	CcSEcCtD
Hydroxyurea—Asthenia—Mycophenolate mofetil—systemic scleroderma	9.81e-05	0.000635	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—systemic scleroderma	9.78e-05	0.000633	CcSEcCtD
Hydroxyurea—Headache—Lisinopril—systemic scleroderma	9.77e-05	0.000632	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—systemic scleroderma	9.63e-05	0.000623	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	9.6e-05	0.000621	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—systemic scleroderma	9.55e-05	0.000618	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—systemic scleroderma	9.49e-05	0.000614	CcSEcCtD
Hydroxyurea—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.35e-05	0.000605	CcSEcCtD
Hydroxyurea—Nausea—Lisinopril—systemic scleroderma	9.27e-05	0.0006	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—systemic scleroderma	9.27e-05	0.0006	CcSEcCtD
Hydroxyurea—Infection—Prednisone—systemic scleroderma	9.2e-05	0.000596	CcSEcCtD
Hydroxyurea—Nervous system disorder—Prednisone—systemic scleroderma	9.09e-05	0.000588	CcSEcCtD
Hydroxyurea—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.04e-05	0.000585	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—systemic scleroderma	9e-05	0.000582	CcSEcCtD
Hydroxyurea—Anorexia—Prednisone—systemic scleroderma	8.83e-05	0.000572	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—systemic scleroderma	8.8e-05	0.00057	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—systemic scleroderma	8.77e-05	0.000567	CcSEcCtD
Hydroxyurea—Vomiting—Mycophenolate mofetil—systemic scleroderma	8.69e-05	0.000562	CcSEcCtD
Hydroxyurea—Rash—Mycophenolate mofetil—systemic scleroderma	8.62e-05	0.000558	CcSEcCtD
Hydroxyurea—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.61e-05	0.000557	CcSEcCtD
Hydroxyurea—Headache—Mycophenolate mofetil—systemic scleroderma	8.56e-05	0.000554	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—systemic scleroderma	8.56e-05	0.000554	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—systemic scleroderma	8.49e-05	0.00055	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—systemic scleroderma	8.22e-05	0.000532	CcSEcCtD
Hydroxyurea—Dyspepsia—Prednisone—systemic scleroderma	8.16e-05	0.000528	CcSEcCtD
Hydroxyurea—Nausea—Mycophenolate mofetil—systemic scleroderma	8.12e-05	0.000525	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—systemic scleroderma	8.05e-05	0.000521	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.02e-05	0.000519	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—systemic scleroderma	7.99e-05	0.000517	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—systemic scleroderma	7.98e-05	0.000516	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—systemic scleroderma	7.92e-05	0.000513	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—systemic scleroderma	7.69e-05	0.000498	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—systemic scleroderma	7.64e-05	0.000494	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—systemic scleroderma	7.59e-05	0.000491	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—systemic scleroderma	7.58e-05	0.000491	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—systemic scleroderma	7.52e-05	0.000487	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—systemic scleroderma	7.38e-05	0.000478	CcSEcCtD
Hydroxyurea—Body temperature increased—Prednisone—systemic scleroderma	7.32e-05	0.000474	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—systemic scleroderma	6.9e-05	0.000447	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—systemic scleroderma	6.88e-05	0.000445	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—systemic scleroderma	6.83e-05	0.000442	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—systemic scleroderma	6.82e-05	0.000441	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—systemic scleroderma	6.73e-05	0.000436	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.68e-05	0.000433	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—systemic scleroderma	6.68e-05	0.000432	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—systemic scleroderma	6.65e-05	0.00043	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—systemic scleroderma	6.62e-05	0.000429	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—systemic scleroderma	6.38e-05	0.000413	CcSEcCtD
Hydroxyurea—Diarrhoea—Prednisone—systemic scleroderma	6.34e-05	0.00041	CcSEcCtD
Hydroxyurea—Dizziness—Prednisone—systemic scleroderma	6.13e-05	0.000396	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—systemic scleroderma	6.12e-05	0.000396	CcSEcCtD
Hydroxyurea—Vomiting—Prednisone—systemic scleroderma	5.89e-05	0.000381	CcSEcCtD
Hydroxyurea—Rash—Prednisone—systemic scleroderma	5.84e-05	0.000378	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—systemic scleroderma	5.84e-05	0.000378	CcSEcCtD
Hydroxyurea—Headache—Prednisone—systemic scleroderma	5.8e-05	0.000376	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—systemic scleroderma	5.7e-05	0.000369	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—systemic scleroderma	5.56e-05	0.00036	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—systemic scleroderma	5.5e-05	0.000356	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—systemic scleroderma	5.3e-05	0.000343	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—systemic scleroderma	5.12e-05	0.000331	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—systemic scleroderma	4.92e-05	0.000319	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—systemic scleroderma	4.88e-05	0.000316	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—systemic scleroderma	4.88e-05	0.000316	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—systemic scleroderma	4.85e-05	0.000314	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—systemic scleroderma	4.6e-05	0.000298	CcSEcCtD
